Latest Updates on Oligonucleotide Synthesis Market : to Reach $26.09 Billion, Globally, by 2030 at 17.1% CAGR , Claims AMR

Allied Market Research recently published a report, titled, "Oligonucleotide Synthesis Market by Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, and Equipment), Application (Therapeutic Applications, Research Applications, and Diagnostic Applications) and End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, the global oligonucleotide synthesis industry was pegged at $5.19 billion in 2020, and is expected to reach $26.09 billion by 2030, growing at a CAGR of 17.1% from 2021 to 2030.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕 𝒂𝒕: https://www.alliedmarketresearch.com/request-sample/8721

𝐌𝐚𝐣𝐨𝐫 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡
Rise in government investments and R&D expenditure in pharmaceutical & biotechnology companies, increase in use of synthesized oligonucleotides in molecular diagnostics and clinical applications, and surge in demand for high end customized oligos and upgradation in purification drive the growth of the global oligonucleotide synthesis market. However, challenging delivery of oligonucleotide drugs to specific targets and complexities associated with therapeutic oligos hinder the market growth. On the contrary, rise in focus on personalized medicines and potential in the developing economies are expected to open lucrative opportunities for the market players in the coming years.

By product, the synthesized oligonucleotides segment is estimated to portray the highest CAGR of 18.1% during the forecast period, due to rise in use of synthesized oligonucleotides in several streams including molecular diagnosis and clinical application. However, the oligonucleotide-based drugs segment held the largest share in 2020, accounting for more than one-third of the global oligonucleotide synthesis market, owing to rise in number of FDA-approved drugs and clinical pipeline of oligonucleotide-based drugs.

𝑻𝒉𝒆 𝒕𝒉𝒆𝒓𝒂𝒑𝒆𝒖𝒕𝒊𝒄 𝒔𝒆𝒈𝒎𝒆𝒏𝒕 𝒅𝒐𝒎𝒊𝒏𝒂𝒕𝒆𝒅 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕
By application, the therapeutic segment held the largest share in 2020, contributing to around two-fifths of the global oligonucleotide synthesis market, owing to rise in research of therapeutic application. However, the research segment is projected to manifest the highest CAGR of 17.6% during the forecast period, owing to rise in approval of several drugs over the last few years.

𝑵𝒐𝒓𝒕𝒉 𝑨𝒎𝒆𝒓𝒊𝒄𝒂 𝒉𝒆𝒍𝒅 𝒕𝒉𝒆 𝒍𝒊𝒐𝒏'𝒔 𝒔𝒉𝒂𝒓𝒆
By region, the global oligonucleotide synthesis market across North America held the largest share in 2020, accounting for more than one-third of the market. This is due to rise in R&D in life sciences, surge in focus on improving the safety & quality of healthcare, increase in demand for high-quality research tools for data reproducibility, and surge in focus on developing personalized therapeutics. However, the market across Asia-Pacific is expected to register the highest CAGR of 18.8% during the forecast period, owing to expanding healthcare infrastructure, surge in government support and investment, and economic development in the region.

𝐌𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬
Alnylam Pharmaceuticals, Inc.
Danaher Corporation
Biogen Inc.
Ionis Pharmaceuticals, Inc.
Eurofins Scientific
LGC Limited
Kaneka Corporation
Sarepta Therapeutics, Inc.
Merck KGAA
Thermo Fisher Scientific, Inc.

𝑲𝒆𝒚 𝑭𝒊𝒏𝒅𝒊𝒏𝒈𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑺𝒕𝒖𝒅𝒚
Based on product, the oligonucleotide-based drugs held the largest share in the global market in 2020.
On the basis of application, the therapeutic application held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
By end user, the hospitals segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 16.00% during the forecast period.

𝐅𝐫𝐞𝐪𝐮𝐞𝐧𝐭𝐥𝐲 𝐀𝐬𝐤𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬?
Which are the top companies hold the market share in Oligonucleotide synthesis market?
Which is the most influencing segment growing in the Oligonucleotide synthesis report?
What are the key trends in the Oligonucleotide synthesis market report?
What are the market values / growth % of emerging countries?
What is the market value of Oligonucleotide synthesis market in 2021?
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

𝑲𝒏𝒐𝒘 𝑴𝒐𝒓𝒆-https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market-A08356

𝑻𝒐𝒑 𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 𝑰𝒏𝒅𝒖𝒔𝒕𝒓𝒚 2024:
𝑴𝒊𝒕𝒓𝒂𝒍 𝑽𝒂𝒍𝒗𝒆 𝑫𝒊𝒔𝒆𝒂𝒔𝒆 𝑻𝒉𝒆𝒓𝒂𝒑𝒆𝒖𝒕𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/smart-medical-devices-market-A17644

𝑫𝒓𝒖𝒈 𝑫𝒆𝒍𝒊𝒗𝒆𝒓𝒚 𝑫𝒆𝒗𝒊𝒄𝒆𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/drug-delivery-devices-market-A06095

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.